Cancer Articles, News & Research Info | Treatment & Drug Trials - Cancer Therapy Advisor

Top News

Vaccines Do Not Reduce the Risk of Severe COVID-19 Among Cancer Patients Receiving Certain Therapies

MRI Is Best for Detecting Breast Cancer in Patients With Dense Breasts and Negative Mammography

Second-Line Bevacizumab Provides No Benefit in Advanced Neuroendocrine Carcinoma

Pandemic-Linked Decline in Cancer Screening Persisted Into 2022

PDE5i Use After Robotic Prostate Cancer Surgery Linked to Better Survival

COVID-19 Vaccination Coverage Hits 76% Among Adults 60 Years and Older

At-Home Medication Errors May Be Common for Children With Leukemia, Lymphoma

COVID-19 Vaccination Tied to Reduced COVID-19 Severity in Breast Cancer

Docetaxel Acts as Radiosensitizer in Head and Neck Cancer

Trodelvy Approved for Pretreated HR+/HER2- Metastatic Breast Cancer

FACT-RNT: A PRO Tool for Prostate Cancer Patients on Radionuclide Therapy

COVID-19 Leading Cause of Death for US Children, Young People

EDITORIAL ADVISORY BOARD

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles

Featured

Cancer Patients May Fall Prey to Illegitimate Online Pharmacies

High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US

Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
ASCO GI 2023

News coverage from the ASCO Gastrointestinal Cancers Symposium
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline

A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Improving End-of-Life Discussions With Cancer Patients

Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.
ASH 2022: MCL Trials Break New Ground, May Change Practice

Mantle cell lymphoma trials presented at ASH 2022 have broken new ground, shown promising results, and may change practice, according to researchers.
ASH 2022: Promising Results in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma

The MonumenTAL-1, MajesTEC-2, OPTIMUM/MUKnine, and GMMG-CONCEPT trials have shown promising results for patients with newly diagnosed or relapsed/refractory multiple myeloma.
AML Research From ASH 2022: Novel Combinations and Evidence That “Less is More”

AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.

More Features

Child with cancer

CAR-T Therapy in Pediatric Leukemia: Past, Present, and Future

By

Heather Stefanski, MD, PhD

CLL cells

ASH 2022: New Findings in CLL

By

Victoria Forster, PhD

Breast cancer

SABCS 2022: Trials Show Improved Outcomes in HR+, HER2- Breast Cancer

By

Alan P. Lyss, MD

ASH 2022: Trials Show Promising Results in Follicular Lymphoma

By

Jonathan Goodman, MPhil

multiracial group racism implicit bias race

Differences in Tumor Biology Could Partly Explain Disparities in Metastatic NSCLC

By

Alan P. Lyss, MD

More Features »

Fact Sheets

Vaccination

Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

COVID-19 testing

What to Expect: Enrolling on a Cancer Clinical Trial During COVID-19